AIMS: Recent studies have suggested that in addition to oxygen transport, red blood cells (RBC) are key regulators of vascular function by both inhibiting and promoting nitric oxide (NO)-mediated vasodilation. Most studies assume that RBC are homogenous, but, in fact, they comprise cells of differing morphology and biochemical composition which are dependent on their age, parameters that control NO reactions. We tested the hypothesis that distinct RBC populations will have differential effects on NO signaling. RESULTS: Young and old RBC were separated by density gradient centrifugation. Consistent with previous reports, old RBC had decreased levels of surface N-acetyl neuraminic acid and increased oxygen binding affinities. Competition kinetic experiments showed that older RBCs scavenged NO∼2-fold faster compared with younger RBC, which translated to a more potent inhibition of both acetylcholine and NO-donor dependent vasodilation of isolated aortic rings. Moreover, nitrite oxidation kinetics was faster with older RBC compared with younger RBC; whereas no differences in nitrite-reduction kinetics were observed. This translated to increased inhibitory effect of older RBC to nitrite-dependent vasodilation under oxygenated and deoxygenated conditions. Finally, leukodepleted RBC storage also resulted in more dense RBC, which may contribute to the greater NO-inhibitory potential of stored RBC. INNOVATION: These results suggest that a key element in vascular NO-homeostasis mechanisms is the distribution of RBC ages across the physiological spectrum (0-120 days) and suggest a novel mechanism for inhibited NO bioavailability in diseases which are characterized by a shift to an older RBC phenotype. CONCLUSION: Older RBC inhibit NO bioavailability by increasing NO- and nitrite scavenging.
AIMS: Recent studies have suggested that in addition to oxygen transport, red blood cells (RBC) are key regulators of vascular function by both inhibiting and promoting nitric oxide (NO)-mediated vasodilation. Most studies assume that RBC are homogenous, but, in fact, they comprise cells of differing morphology and biochemical composition which are dependent on their age, parameters that control NO reactions. We tested the hypothesis that distinct RBC populations will have differential effects on NO signaling. RESULTS: Young and old RBC were separated by density gradient centrifugation. Consistent with previous reports, old RBC had decreased levels of surface N-acetyl neuraminic acid and increased oxygen binding affinities. Competition kinetic experiments showed that older RBCs scavenged NO∼2-fold faster compared with younger RBC, which translated to a more potent inhibition of both acetylcholine and NO-donor dependent vasodilation of isolated aortic rings. Moreover, nitrite oxidation kinetics was faster with older RBC compared with younger RBC; whereas no differences in nitrite-reduction kinetics were observed. This translated to increased inhibitory effect of older RBC to nitrite-dependent vasodilation under oxygenated and deoxygenated conditions. Finally, leukodepleted RBC storage also resulted in more dense RBC, which may contribute to the greater NO-inhibitory potential of stored RBC. INNOVATION: These results suggest that a key element in vascular NO-homeostasis mechanisms is the distribution of RBC ages across the physiological spectrum (0-120 days) and suggest a novel mechanism for inhibited NO bioavailability in diseases which are characterized by a shift to an older RBC phenotype. CONCLUSION: Older RBC inhibit NO bioavailability by increasing NO- and nitrite scavenging.
Authors: Mahesh S Joshi; T Bruce Ferguson; Tae H Han; Daniel R Hyduke; James C Liao; Tienush Rassaf; Nathan Bryan; Martin Feelisch; Jack R Lancaster Journal: Proc Natl Acad Sci U S A Date: 2002-07-17 Impact factor: 11.205
Authors: Chenell Donadee; Nicolaas J H Raat; Tamir Kanias; Jesús Tejero; Janet S Lee; Eric E Kelley; Xuejun Zhao; Chen Liu; Hannah Reynolds; Ivan Azarov; Sheila Frizzell; E Michael Meyer; Albert D Donnenberg; Lirong Qu; Darrel Triulzi; Daniel B Kim-Shapiro; Mark T Gladwin Journal: Circulation Date: 2011-07-11 Impact factor: 29.690
Authors: Ernst E van Faassen; Soheyl Bahrami; Martin Feelisch; Neil Hogg; Malte Kelm; Daniel B Kim-Shapiro; Andrey V Kozlov; Haitao Li; Jon O Lundberg; Ron Mason; Hans Nohl; Tienush Rassaf; Alexandre Samouilov; Anny Slama-Schwok; Sruti Shiva; Anatoly F Vanin; Eddie Weitzberg; Jay Zweier; Mark T Gladwin Journal: Med Res Rev Date: 2009-09 Impact factor: 12.944
Authors: Ryan Stapley; Cilina Rodriguez; Joo-Yeun Oh; Jaideep Honavar; Angela Brandon; Brant M Wagener; Marisa B Marques; Jordan A Weinberg; Jeffrey D Kerby; Jean-Francois Pittet; Rakesh P Patel Journal: Free Radic Biol Med Date: 2015-04-29 Impact factor: 7.376
Authors: Thomas J van 't Erve; Claire M Doskey; Brett A Wagner; John R Hess; Benjamin W Darbro; Kelli K Ryckman; Jeffrey C Murray; Thomas J Raife; Garry R Buettner Journal: Free Radic Biol Med Date: 2014-08-07 Impact factor: 7.376
Authors: Evan Paul Tracy; William Hughes; Jason E Beare; Gabrielle Rowe; Andreas Beyer; Amanda Jo LeBlanc Journal: Antioxid Redox Signal Date: 2021-09-17 Impact factor: 7.468
Authors: Chen Liu; Xiaohua Liu; John Janes; Ryan Stapley; Rakesh P Patel; Mark T Gladwin; Daniel B Kim-Shapiro Journal: Redox Biol Date: 2014-01-10 Impact factor: 11.799
Authors: Sara E Lewis; Courtney B Rosencrance; Evan De Vallance; Andrew Giromini; Xena M Williams; Joo-Yeun Oh; Heidi Schmidt; Adam C Straub; Paul D Chantler; Rakesh P Patel; Eric E Kelley Journal: Free Radic Biol Med Date: 2021-07-15 Impact factor: 8.101